MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-18-2026
InspireMD Market Cap 2011-2026 | NSPR
As of April 27, 2026 InspireMD has a market cap of $ 80.4 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap InspireMD
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115 M | 75.1 M | 63.6 M | 8.74 M | 22.2 M | 15.7 M | 2.47 M | 4.15 M | 371 K | 99.1 K | 116 K | 900 K | 2.3 M | 1.63 B | 2.92 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.63 B | 99.1 K | 130 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
139 M | $ 3.22 | -2.57 % | $ 121 M |  France |
 |
Align Technology
ALGN
|
13.9 B | $ 189.61 | -0.56 % | $ 14.2 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
AdaptHealth Corp.
AHCO
|
1.2 B | $ 12.8 | 0.55 % | $ 1.73 B | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 2.16 | 4.85 % | $ 1.31 M | USA |
 |
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
34.8 M | $ 0.63 | -3.04 % | $ 39.2 M | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 16.19 | -0.12 % | $ 380 M | USA |
 |
ClearPoint Neuro
CLPT
|
316 M | $ 11.78 | 9.58 % | $ 334 M | USA |
 |
LivaNova PLC
LIVN
|
3.81 B | $ 64.2 | -1.45 % | $ 3.5 B |  Britain |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
17 M | - | - | $ 10.2 M | USA |
 |
Pulmonx Corporation
LUNG
|
72.8 M | $ 1.27 | -0.78 % | $ 51.7 M | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
Electromed
ELMD
|
175 M | $ 26.39 | 3.57 % | $ 223 M | USA |
 |
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | USA |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
12.5 B | $ 94.87 | 0.52 % | $ 12.8 B | USA |
 |
Orthofix Medical
OFIX
|
491 M | $ 12.35 | 1.65 % | $ 489 M |  Curacao |
 |
Butterfly Network
BFLY
|
766 M | $ 5.33 | 3.5 % | $ 1.13 B | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
Delcath Systems
DCTH
|
326 M | $ 10.84 | 1.88 % | $ 388 M | USA |
 |
IRIDEX Corporation
IRIX
|
16.6 M | $ 1.06 | 0.95 % | $ 18 M | USA |
 |
Insulet Corporation
PODD
|
18.1 B | $ 189.56 | -1.38 % | $ 13.3 B | USA |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 38.34 | 2.24 % | $ 1.19 B | USA |
 |
Inspire Medical Systems
INSP
|
1.76 B | $ 56.31 | -0.07 % | $ 1.65 B | USA |
 |
Integer Holdings Corporation
ITGR
|
2.98 B | $ 86.02 | 1.37 % | $ 2.99 B | USA |
 |
PAVmed
PAVM
|
5.81 M | $ 9.0 | -1.85 % | $ 6.03 M | USA |
 |
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
48.8 B | $ 84.15 | 5.56 % | $ 49.2 B | USA |
 |
LENSAR
LNSR
|
71.3 M | $ 5.09 | -3.23 % | $ 60.9 M | USA |
 |
Sintx Technologies
SINT
|
6.91 M | $ 2.47 | -1.59 % | $ 6.85 M | USA |
 |
MiMedx Group
MDXG
|
779 M | $ 3.43 | 2.39 % | $ 507 M | USA |
 |
Stryker Corporation
SYK
|
147 B | $ 327.51 | -0.65 % | $ 125 B | USA |